A 13-gene colorectal cancer liquid biopsy with greater than 90 percent accuracy in diagnosis and assessment of disease status.
Modlin I, Kidd M, Drozdov I, Kitz A, Malczewska A, Kusnierz K, Aslanian H. A 13-gene colorectal cancer liquid biopsy with greater than 90 percent accuracy in diagnosis and assessment of disease status. Journal Of Clinical Oncology 2020, 38: 18-18. DOI: 10.1200/jco.2020.38.4_suppl.18.Peer-Reviewed Original ResearchColorectal cancerStable diseaseProgressive diseaseClinical utilityCA 19CRC tumorsCancer liquid biopsyLiquid biopsyBlood-based biomarkersSurgical resectionChemotherapy patientsDisease burdenScore utilityBlood signatureBlood samplesAUROC analysisDisease statusDiagnostic accuracyGene expressionDiseaseCandidate markersResectionExpression levelsBiopsyCEA